NASDAQ NMS - GLOBAL MARKET · ENTA
+2.59% · +$0.3400 · Vol 335.2K
Market closed · last close 4:00 PM ET · price as of 16:04:45 ET
Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc

Biotechnology
$13.47
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
ENTA
Enanta Pharmaceuticals Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

54/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ENTA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ENTA catalysts
About Enanta Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2013
Employees
120
Country
US

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$13.27
Day high
$13.70
Day low
$13.09
Previous close
$13.13
52W high
$16.85
-20.06% from high
52W low
$7.17
65% of range
Market cap
$392.3M
EPS
$-2.6000
Beta
0.20
Shares out
29.1M
Volume
335.2K
1.93× rel vol
Avg volume
173.7K
VWAP
$13.43
Price history computed in-house
1W
+4.99%
1M
+5.40%
3M
-0.44%
1Y
+52.55%
YTD
-14.58%
SMA 50 $13.34 · above
SMA 200 $13.49 · below
52W position 65%

ENTA overview

Loading financial statements
Loading ENTA Form 4 filings
Public disclosures

Congress activity in ENTA

Federal contracts

ENTA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ENTA in this window.
Lobbying spend

ENTA lobbying filings, year to date.

Registered lobbying filings matched to Enanta Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ENTA in this window.
Loading news for ENTA
Analyst ratings
Sovereign unlock shows live analyst consensus for ENTA.
Options
Sovereign unlock shows live options positioning for ENTA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.